E2F1 and neuroblastoma: Similar with the results from TARGET and GSE85047 datasets, neuroblastoma patients with higher expression levels of E2F1 were associated with the lower event free survival in GSE16476 and E-MTAB-1781 datasets (Fig. 3a).